首页
订购/客服:400-666-5481

GL0388

    
≥98%

源叶(MedMol)
V48009 一键复制产品信息
2886772-68-3
C21H17FN2O
332.37
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V48009-5mg
≥98%

¥2640.00

货期:3-5天 - - - -
V48009-10mg
≥98%

¥4190.00

货期:3-5天 - - - -
V48009-25mg
≥98%

¥7530.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: GL0388 is a Bax activator that results in Bax insertion into mitochondrial membrane. GL0388 shows antiproliferative activities against various cancer cells, with IC50s of 0.299-1.57 μM. GL0388 activates Bax and induce Bax-mediated apoptosis. GL0388 suppresses breast cancer xenograft tumor growth in vivo.
靶点: Bax
体外研究: GL0388 (0.1-10 μM; 72 h) inhibits the cell proliferation of MDA-MB-231 and MCF-7 breast cancer cell lines, with IC50s of 0.96 μM and 0.52 μM, respectively.
GL0388 (0.01-100 μM) inhibits the cell proliferation in 60 human tumor cell lines, with GI550s of 0.299-1.57 μM.
GL0388 (1-10 μM; 48 h) significantly upregulates the cleaved PARP-1 and cleaved caspase 3 in MDA-MB-231 cells.
GL0388 (0.1-1 μM; 24 h) inhibits the colony formation and invasion of breast cancer cells.
GL0388 (1-10 μM; 24 h) promotes Bax insertion into mitochondrial membranes of MDA-MB-231 cells in a dose-dependent manner. GL0388 increases cytochrome c in the cytosolic fraction of MDA-MB-231 cells.
体内研究: GL0388 (10-20 mg/kg for i.p.; 15 mg/kg for i.t.; once daily for 10 days) dose-dependently suppresses the growth of MDA-MB-231 tumors in mice.
参考文献: 1. Liu G, et, al. Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer. Eur J Med Chem. 2021 Jul 5;219:113427.
保存条件: -20°C
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.009 ml 15.043 ml 30.087 ml
5 mM 0.602 ml 3.009 ml 6.017 ml
10 mM 0.301 ml 1.504 ml 3.009 ml
50 mM 0.06 ml 0.301 ml 0.602 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×